| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.001 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |